Stop being the product.
Become the owner.
or
sign uplog in

A study tracking 2,525 ulcerative colitis patients reveals…

A study tracking 2,525 ulcerative colitis patients reveals which treatments last longest in real-world settings. Vedolizumab significantly outlasts standard anti-TNF drugs, while upadacitinib proves to be the most durable backup option if initial therapies fail.
#science
earnings
3,000 mlx total
$0  total
engagement
4 views
0 reactions

0 comments